Term
|
Definition
prototypical TYPICAL ANTI-PSYCOTIC
D1 receptor agonist (mostly)
1. Least Potent; most sedative
2. can cause HYPOTENSION AND WEIGHT GAIN, dry mouth, galactorrhea,
Extrapyrimidal effects come from D2 receptor blockade |
|
|
Term
|
Definition
Typical anti-psycotic
Associated with neuroleptic malignant syndrome |
|
|
Term
|
Definition
typical anti-psycotic
typical side effects |
|
|
Term
|
Definition
typical anti-psycotic
HIGHEST EXTRAPYRAMIDAL EFFECTS
May cause MALIGNANT NEUROLEPTIC SYNDROME: triad rigidity, fever, and cognitive changes due to hypoactivation D2... Treat with benzo or dantrolene |
|
|
Term
|
Definition
Prototypical ATYPICAL ANTI-PSYCOTIC
not used because of Agranulocytosis; weight gain; hypotension.. good for suicide patients |
|
|
Term
|
Definition
Atypical Anti-psycotic
Only PARTIAL D2 agonist. Associated with least amount of extrapyrimidal and sedative effects. |
|
|
Term
|
Definition
Atypical Antipsycotic
Least associated with weightgain. MOST ASSOCIATED WITH PROLONGED QT. |
|
|
Term
|
Definition
| Atypical anti-psycotic associated with EXTRAPYRIMIDAL EFFECTS |
|
|
Term
|
Definition
| atypical antipsycotic associated with EXTRAPYRIMIDAL EFFECTS AND WEIGHT GAIN |
|
|
Term
|
Definition
|
|
Term
| Neuroleptic malignant syndrome |
|
Definition
rigidity, fever, cognitive changes
treat dantrolene |
|
|
